Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 465 entries
View as:

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00440557 Org: User:
Start: 09/30/06 End: 02/29/08 Due: 02/28/09

A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00650793 Org: User:
Start: 03/31/04 End: 02/28/06 Due: 02/28/07

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00113607 Org: User:
Start: 04/30/05 End: 11/30/10 Due: 11/30/11

Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00210756 Org: User:
Start: 02/29/04 End: 02/28/06 Due: 02/28/07

A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT01041859 Org: User:
Start: 12/31/09 End: 03/31/11 Due: 03/31/12

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01714193 Org: User:
Start: 02/29/08 End: 03/31/08 Due: 03/31/09

A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02103985 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10

A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00490971 Org: User:
Start: 05/31/06 End: 04/30/10 Due: 04/30/11

A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00309686 Org: User:
Start: 04/30/06 End: 08/31/07 Due: 08/31/08

A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00880217 Org: User:
Start: 05/31/09 End: 01/31/10 Due: 01/31/11

Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00304603 Org: User:
Start: 04/30/04 End: 04/30/05 Due: 04/30/06

A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01340677 Org: User:
Start: 05/31/11 End: 08/31/11 Due: 08/31/12

A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain

Phase: N/A Priority: Normal
NCT ID: NCT01586507 Org: User:
Start: 10/31/07 End: 09/30/08 Due: 09/30/09

The Duration Study

Phase: N/A Priority: Normal
NCT ID: NCT00210730 Org: User:
Start: 06/30/04 End: 07/31/05 Due: 07/31/06

A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.

Phase: N/A Priority: Normal
NCT ID: NCT00709332 Org: User:
Start: 01/31/05 End: 02/28/05 Due: 02/28/06

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00236691 Org: User:
Start: 07/31/88 End: 12/31/90 Due: 12/31/91

An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01286090 Org: User:
Start: 07/31/03 End: 10/31/03 Due: 10/31/04

A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain

Phase: N/A Priority: Normal
NCT ID: NCT01060254 Org: User:
Start: 04/06/10 End: 06/24/11 Due: 06/24/12

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

Phase: N/A Priority: Normal
NCT ID: NCT00094926 Org: User:
Start: 05/31/04 End: 02/28/07 Due: 02/28/08

A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00986128 Org: User:
Start: 03/31/01 End: 10/31/02 Due: 10/31/03

Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00036400 Org: User:
Start: 12/31/01 End: 12/31/03 Due: 12/31/04

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00270127 Org: User:
Start: 08/31/96 End: 09/30/98 Due: 09/30/99

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

Phase: N/A Priority: Normal
NCT ID: NCT00416169 Org: User:
Start: 05/31/03 End: 07/31/04 Due: 07/31/05

A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies

Phase: N/A Priority: Normal
NCT ID: NCT01054352 Org: User:
Start: 02/28/10 End: 03/31/11 Due: 03/31/12

A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00299715 Org: User:
Start: 02/28/06 End: 06/30/07 Due: 06/30/08